Algos Selects Methadex As Tradename For Heroin Abuse Therapy
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Algos Pharmaceutical has chosen the tradename Methadex for a combination methadone/dextromethorphan product in Phase II trials for treatment of heroine addiction. The company filed the name with the Patent and Trademark Office for analgesic and anesthetic preparations.